Introducing QuantumRF: The Next Generation of Skin Tightening
Leading the 2025 aesthetic landscape is InMode's groundbreaking non-suction QuantumRF technology for facial and body treatments. This advanced fractional bi-polar radiofrequency (RF) treatment safely targets the deep layers of the skin, stimulating collagen production and tightening the skin without the need for incisions or surgery. This treatment is particularly effective for those looking for a single-session minimally invasive treatment to combat sagging skin, reduce fat, and improve fine lines and wrinkles.
What sets QuantumRF apart is its precision and customisable settings, allowing surgeons to tailor the treatment to everyone, regardless of age, gender or skin type. QuantumRF reduces the challenge of limited theatre time, and can be used in a theatre environment, or as an in-office procedure. It is a sought-after alternative to brachioplasties and thighplasties as there is no cutting or scarring. According to leading Plastic surgeon, Dr Alfredo Hoyos, this technology is set to become the go-to solution for those seeking a quick, effective, and safer, treatment to achieve youthful, rejuvenated, and firmer skin. With minimal discomfort and downtime, it is expected that QuantumRF will follow the global trend and be widely adopted by aesthetic surgeons throughout Australia. InMode QuantumRF
Morpheus8 Burst with Scaleä: Revolutionising Skin Rejuvenation and Contouring
Building upon the global success of Morpheus8, InMode introduces Morpheus8 Burst with Scaleä technology. The introduction of the next-generation Morpheus8 Burst and Burst Deep will build on InMode's industry-leading position for individuals looking for a more dramatic skin-tightening and shaping effect. Minimally invasive, non-surgical and with less downtime and discomfort, this technology will continue to rise in popularity in the new year. InMode Morpheus8 Looking Ahead: Trends to Watch in 2025
The aesthetic industry is witnessing a significant shift towards treatments that provide natural results with minimal intervention, particularly the rise of rapid weight loss with associated loose skin. InMode's suite of technologies aligns with this trend, emphasising minimally invasive procedures that deliver effective outcomes without extensive downtime and provide the option of having treatments performed in-theatre or in-office. As we progress through 2025, expect to see a growing preference for such treatments, with InMode leading the charge in innovation and patient satisfaction. About InMode Australia
InMode is a leading global provider of innovative medical aesthetic technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology, light-based applications including IPL and laser, and EMS. InMode strives to enable new emerging non-surgical procedures as well as improving and complimenting existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories including plastic and cosmetic surgery, dermatology, optometry and ophthalmology, gynaecology and women's health, and cosmetic clinics.
